[Hemostasis and T-cell immunity in lung cancer patients].
Complex examination of hemostatic system and T-cell-mediated immunity in 19 cases of stage II-IV lung cancer showed an increased activity of blood coagulation system to be associated with a decrease in OKT3+, OKT11+ and OKT4+ T-lymphocyte subsets levels. A reverse correlation was established between plasma--Willebrand's factor level and those of OKTè+ and OKT8+ lymphocytes whereas a direct one--between blood-platelet aggregate level and that of OKT4+. The data obtained emphasized the need to consider the status of hemostatic system when evaluating the function of cell-mediated immunity.
Moiseev
S I
SI
Kravtsova
V M
VM
Efimov
K V
KV
Evtiukhin
A I
AI
Afanas'ev
B V
BV
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D001780:Blood Coagulation Tests; D006487:Hemostasis / Q000502:physiology*; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000276:immunology; D008875:Middle Aged; D011184:Postoperative Period; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000954:Antigens, Surface
Gemostaz i T-kletochnyĭ immunitet u bol'nykh rakom legkogo.